Science Explorer Back to mapMap
Discussion
Researcher · University of British Columbia · Canada

Torsten O. Nielsen

Torsten O. Nielsen publishes mostly in Oncology, Cancer Research and Molecular Biology, on topics such as Breast Cancer Treatment Studies, Sarcoma Diagnosis and Treatment and HER2/EGFR in Cancer Research.

ORCID 0000-0003-3769-2517 OpenAlex
World rank
#16,001
of 7,710,434 ranked researchers
Rank in Canada
#321
of 183,316
Works
484
Citations
56k
Citations per work
115.4
h-index
105
i10-index 238Top 0.3% in Oncology
Torsten O. Nielsen

What does Torsten O. Nielsen research?

Torsten O. Nielsen's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (38%).

Health Sciences: 186 works · 38.4% of their workMedicine: 186 works · 38.4% of their workOncology: 91 works · 18.7% of their workPulmonary and Respiratory Medicine: 60 works · 12.3% of their workPathology and Forensic Medicine: 36 works · 7.4% of their workLife Sciences: 182 works · 37.6% of their workBiochemistry, Genetics and Molecular Biology: 182 works · 37.6% of their workCancer Research: 85 works · 17.6% of their workMolecular Biology: 77 works · 15.9% of their workGenetics: 20 works · 4.1% of their workEverything else: 116 works · 24.0% of their workTHEIR WORKTorsten O.Nielsen484works
Life Sciences38%Health Sciences38%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine18638.4%
    1. Biochemistry, Genetics and Molecular Biology18237.6%
  3. Everything else11624.0%
  1. 1Oncology19% of their works
  2. 2Cancer Research18% of their works
  3. 3Molecular Biology16% of their works
  4. 4Pulmonary and Respiratory Medicine12% of their works
  5. 5Pathology and Forensic Medicine7% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe Torsten O. Nielsen's research?

The keywords of their largest research topics: Clinical Practice Guidelines, Chemotherapy, Breast Cancer, Breast Tumours, Gene Expression, Osteosarcoma, Soft Tissue Sarcoma and HER2.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Clinical Practice Guidelines2202 topics
  2. Chemotherapy1542 topics
  3. Breast Cancer1514 topics
  4. Breast Tumours1291 topic
  5. Gene Expression1291 topic
  6. Osteosarcoma911 topic
  7. Soft Tissue Sarcoma911 topic
  8. HER2631 topic
  9. Trastuzumab631 topic
  10. Cancer Genomics441 topic
  11. Mutational Signatures441 topic
  12. Mammography431 topic
  13. Ultrasound431 topic
  14. Immune Checkpoint Blockade421 topic
  15. PD-1 and PD-L1421 topic
  16. Estrogen231 topic
  17. Receptor231 topic
  18. CDK4/6 Inhibitors221 topic
  19. Palbociclib221 topic

Where does Torsten O. Nielsen work?

Torsten O. Nielsen's main affiliation in the publication record is University of British Columbia, Canada.

How many publications and citations does Torsten O. Nielsen have?

OpenAlex counts 484 works and 55,836 citations for Torsten O. Nielsen, an h-index of 105, ranking #16,001 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Torsten O. Nielsen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.